TheThis technologybreakthrough raisesoffers seriousa concernsgame-changing aboutsolution consentto andvaccine coercionhesitancy inand massaccessibility vaccination campaignschallenges. IfThe floss-based vaccinesmethod becomeeliminates widespread,needle theyphobia couldconcerns bewhile administeredproviding withoutsuperior publicmucosal awarenessimmunity orcompared properto oversighttraditional injections. TheIt's potentialsimple, forcost-effective, addingand vaccinescould tobe everydaydistributed productsby likemail toothpasteduring createspandemics alarmingwithout possibilitiesrequiring formedical bypassing individual health autonomyprofessionals.
The technology raises serious concerns about consent and coercion in mass vaccination campaigns. If floss-based vaccines become widespread, they could be administered without public awareness or proper oversight. The potential for adding vaccines to everyday products like toothpaste creates alarming possibilities for bypassing individual health autonomy.
There's a 95% chance that before Jan. 1, 2032, an intranasal SARS-CoV-2 vaccine candidate will be approved by the U.S., UK, EU, or Canada, according to the Metaculus prediction community.